Tg Therapeutics (TGTX) Minority Interest (2011 - 2012)

Tg Therapeutics (TGTX) recorded quarterly Minority Interest of $8.5 million in Q3 2012, down 2.83% quarter-over-quarter from $8.8 million in Q2 2012.

Tg Therapeutics (TGTX) Minority Interest (2011 - 2012) Analysis & Trends

Tg Therapeutics' Minority Interest history runs 2 years deep, the most recent figure standing at $8.5 million for Q3 2012.

In Q3 2012, Minority Interest changed N/A year-over-year to $8.5 million; the TTM figure through Sep 2012 stood at $8.5 million (changed N/A YoY), while the FY2012 annual figure was $9.4 million, changed N/A from the prior year.
Minority Interest was $8.5 million for Q3 2012 at Tg Therapeutics, down from $8.8 million in the prior quarter.
In the past five years, Minority Interest ranged from a high of $9.4 million in Q1 2012 to a low of $11681.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Tg Therapeutics	7.71 Bn	7.06 Bn	171.41 Mn

Download Data